ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,454Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 315

$1.52M Total Retail Price of All Prescriptions

Rank: 6 out of 315

516 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 13,078 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$113 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LOSARTAN POTASSIUM 648 632 1 4
PRAVASTATIN SODIUM 575 568 2 10
CARVEDILOL 445 438 3 22
SIMVASTATIN 439 418 4 1
OMEPRAZOLE 385 354 5 9
AMLODIPINE BESYLATE 382 374 6 2
CRESTOR 371 344 7 24
SYNTHROID 344 340 8 51
ATORVASTATIN CALCIUM 319 317 9 5
LEVOTHYROXINE SODIUM 303 295 10 6
ALENDRONATE SODIUM 277 277 11 12
LOVAZA 242 234 12 64
CLOPIDOGREL 241 228 13 25
METOPROLOL SUCCINATE 231 231 14 13
POTASSIUM CHLORIDE 220 219 15 36
PLAVIX 213 207 16 40
POLYETHYLENE GLYCOL 3350 210 209 17 106
PANTOPRAZOLE SODIUM 206 198 18 35
FUROSEMIDE 198 193 19 15
FORTEO 198 198 19 167
DONEPEZIL HCL 194 193 21 28
NIASPAN 185 179 22 103
NAMENDA 171 171 23 38
FAMOTIDINE 170 168 24 75
FOLIC ACID 164 162 25 152
ACTONEL 152 148 26 47
PEN NEEDLE 127 127 27 91
NIFEDIPINE ER 125 125 28 67
ALLOPURINOL 122 120 29 14
LOSARTAN-HYDROCHLOROTHIAZIDE 121 110 30 17
TAMSULOSIN HCL 121 121 30 21
ZETIA 118 114 32 84
EVISTA 114 114 33 48
FENOFIBRATE 100 94 34 43
METFORMIN HCL 100 98 34 7
GLIMEPIRIDE 100 89 34 32
RANITIDINE HCL 96 94 37 42
LANTUS SOLOSTAR 91 85 38 69
LIPITOR 89 89 39 44
CARBIDOPA-LEVODOPA 69 69 40 136
WARFARIN SODIUM 67 67 41 20
CITALOPRAM HBR 66 66 42 72
MIRTAZAPINE 65 65 43 68
VITAMIN D2 64 61 44 134
ESCITALOPRAM OXALATE 63 60 45 108
KLOR-CON 10 63 52 45 183
PREDNISONE 62 61 47 41
GABAPENTIN 58 58 48 37
JANUVIA 58 58 48 31
CIPROFLOXACIN HCL 57 55 50 58
AVELOX 54 53 51 217
VERAPAMIL ER 54 54 51 94
RAMIPRIL 53 52 53 104
NIFEDIAC CC 53 53 53 97
HYDROCORTISONE 52 52 55 200
NIFEDICAL XL 51 51 56 263
HUMALOG 50 46 57 219
SPIRONOLACTONE 50 50 57 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.